Blogs

How Much Research Do You Actually Need for U.S. Residency? Ask ten medical students how much research they need for residency, and you’ll get ten different panicked answers — most of them wrong. The truth is less dramatic than Reddit makes it sound, but it’s also not one-size-fits-all. It depends almost entirely on what specialty you’re chasing.  It’s About Your Specialty, Not a Magic Number.  There’s no universal research quota. A future dermatologist and a future family medicine doctor are playing completely different games. Programs aren’t grading you against some abstract “good applicant” — they’re comparing you to the typical person who matches into that specific field.  Roughly speaking, the ultra-competitive, research-obsessed specialties — think neurosurgery, plastic surgery, dermatology, ENT — tend to see applicants show up with somewhere between 10 and 20-plus scholarly items, sometimes more. On the other end, family medicine, psychiatry, and similar fields often see successful applicants with just a handful, sometimes even zero. The middle ground — internal medicine, general surgery, OB/GYN, pediatrics — is where things get murkier. A community-focused IM program might barely blink at two or three items, while a big-name academic program in the same specialty could expect six to ten. What Actually Counts as “Research” Here’s where a lot of students psych themselves out. You don’t need a first-author paper in a major journal to have something worth listing. ERAS is far more generous than people assume. Posters, conference abstracts, case reports, quality improvement projects, book chapters, even well-documented curriculum work — all of it counts as scholarly activity. If you helped with a chart review, cleaned up messy data, or contributed meaningfully to a poster that got presented at a regional conference, that’s legitimate. You don’t need to have been the mastermind behind the project. What doesn’t hold up, though, is padding your CV with things you can’t actually explain. If an interviewer asks about your “research experience” and you can’t describe the question being studied or what the results showed, that’s going to hurt you more than having a thinner CV would. Quality Still Beats Quantity Recent changes to how ERAS applications work have actually pushed things in a more sensible direction — applicants can now flag their most meaningful experiences instead of just dumping a long list. One solid, first-author paper in a decent journal will do more for you than five padded, barely-touched entries. Program directors have seen enough CVs to spot the difference between genuine contribution and résumé filler. Don’t Lose Sight of the Bigger Picture Here’s the part that gets buried under all the research anxiety: it’s not the top priority for most programs. Your USMLE Step scores, the strength of your letters of recommendation, and how you performed on actual clinical rotations still carry more weight for the vast majority of specialties and programs. Research helps you stand out, especially at academic and university-affiliated programs, but it was never designed to replace the basics. If you’re weighing whether to spend another summer chasing a publication or shoring up your clinical skills and exam prep, the second option usually pays off more — unless you’re specifically targeting one of those research-heavy fields where it’s simply expected. So, How Much Do You Really Need? Start by being honest about your specialty and where you’re aiming — community program, mid-tier academic center, or a top-tier research powerhouse. From there, a realistic target becomes much clearer, and a lot less scary than the internet makes it sound. If it helps, I can walk through this with your specific specialty and background (IMG or U.S. grad) and put together a more tailored research plan and timeline.

How Many Research Publications Do You Need to Match Into U.S. Residency? There’s no universal number. Research expectations for the Match swing from zero to well over thirty scholarly items depending on specialty, and program directors weigh quality far more heavily than a raw count. Research Expectations by Specialty Primary care and less research-driven fields. Family Medicine, Emergency Medicine, and Pediatrics programs generally expect little to no peer-reviewed work — a median of zero to one publication is common among matched applicants. Mid-tier and moderately competitive fields. Internal Medicine and Neurology applicants typically match comfortably with one to five research items, whether that’s publications, abstracts, or posters. Competitive, research-heavy specialties. Dermatology, Plastic Surgery, Orthopedic Surgery, andNeurosurgery are a different game entirely. Matched applicants in these fields often report ten to thirty-plus total research items once abstracts and presentations are counted alongside full papers. Quality Still Beats Quantity A thin CV with one or two first-author, peer-reviewed articles you can defend in detail during an interview outperforms a long list of middle-author abstracts you can barely summarize. The NRMP itself separates publications, abstracts, and presentations in its tracking specifically because program directors want to see the shape of an applicant’s scholarly output, not just its size. Where the Real Bottleneck Is For International Medical Graduates in particular, the challenge usually isn’t ambition — it’s access. Getting meaningful, hands-on research experience from outside the U.S. system, finding a mentor willing to guide a project through to submission, and producing something publication-ready within the Match timeline is a genuinely hard logistical problem. This is exactly the gap that structured research fellowships are designed to close. One option worth knowing about is the MD Research Consortium’s research fellowship, run under the direct mentorship of Dr. Indranill Basu-Ray, a cardiac electrophysiologist and prolific researcher with a substantial peer-reviewed publication record and academic appointments spanning Harvard Medical School, AIIMS Rishikesh, and MIT’s LinQ program. The program is built specifically for IMGs preparing for U.S. residency applications and centers on a few concrete deliverables: Structured, three-month training in research methodology, with the option to extend for applicants pursuing guaranteed publication. Direct mentorship from a physician-researcher with an extensive publication history and journal editorial experience, rather than a loosely supervised solo project. A defined path to output — abstracts or peerreviewed papers — matched to the standards applicants actually need to discuss credibly at interview. Letters of recommendation grounded in real, substantive research involvement, which carry more weight with program directors than a generic clinical observership letter. Flexibility to run alongside a clinical observership, so applicants can build both clinical exposure and a research record in the same stretch of time. For an IMG targeting Internal Medicine, Neurology, or a more research-intensive specialty, a program like this addresses the actual constraint — mentorship and structure — rather than just producing volume. A candidate walking into an interview with two or three well-understood, mentor-guided publications is in a stronger position than one with a dozen items they can’t speak to in depth. The Bottom Line Don’t chase a number. Match your research output to your specialty’s actual norms, and prioritize depth over volume everywhere. If access to a real research pipeline — a mentor, a methodology, and a path to submission — is the missing piece, a structured fellowship like the one Dr. Basu-Ray leads through the MD Research Consortium is worth evaluating as a way to close that gap before application season.

How to Build Strong Research Profile While Preparing for USMLE Do a reality check before you read this guide. Imagine a program director opening your ERAS file and seeing your research statement. Would they have second thoughts about inviting you for an interview?  If you answered positively, it means that you need our guide on building a strong research profile.  The first impression of your application is a critical moment. And nowadays almost every candidate manages to get a satisfactory score on Step 2 CK. Therefore, what can distinguish you from others applying to the same specialty? A couple of well-described clinical observations that you can discuss during your interview in-depth. To do that, you need to know your research inside-out and be able to defend every part of it during an interview. Here are some useful suggestions on how to do that while preparing for your boards Rule #1: Small and Finished Beats Big and Abandoned Research projects that get completed are always smaller in scale than those abandoned due to a lack of time. During the preparation for your boards, you are likely to have a limited amount of time and energy. Hence, it is wise to pick a project that can be finished before your exam. A successful endeavor will also look better on your CV than a couple of unfinished trials. Below are several evidence-based suggestions that will help you get a meaningful research experience. Case reports-. One weird patient, nicely wrapped up. Quick to write, cheap on resources.  Systematic reviews and meta-analyses-. Abstract screening and data extraction can be done anywhere with a Wi-Fi connection. Posters and abstracts-. A conference submission is a real, citable, peer-reviewed scholarly output. Think about the smallest unit of analysis that you can realistically publish within 8-12 weeks. Rule #2: Mentorship Beats Motivation Motivation dwindles by week three. A mentor will keep you on track beyond that Start by asking which of your own faculty is publishing, and ask to help collect data for or draft a paper—just don’t refer to it as “mentoring.” Call your seniors. Ask alumni who’ve already matched if they’re aware of any research opportunities; many are maintaining long-distance collaborations and can recommend you to their networks. Avoid generic, impersonal outreach. “Do you have research opportunities?” will get ignored. “I read your 2025 paper on X—can I help with your work on Y?” won’t. This is the sort of resource that organizations like MD Research (mdresearch.us) exist to fill: formal mentoring programs for IMGs without local connections to pursue research opportunities. The program is led by Dr. Indranill Basu-Ray, cardiologist and cardiac electrophysiologist at the Memphis VA Medical Center and University of Memphis Adjunct Professor, who has contributed to over a hundred peer-reviewed publications. For those with few local options, a formal mentoring program with an established faculty lead can provide a valuable shortcut to months of fruitless outreach. Rule #3: Protect Step 2 CK Like It’s Non-Negotiable Here’s the uncomfortable truth: a brilliant publication will not rescue a weak Step 2 CK score. Program directors sort applications by scores first – research is what differentiates a borderline application from a mediocre one, not that it compensates for a poor score. Build a firewall. Limit your USMLE study hours first – then fit research into whatever time remains – evenings, weekends, one intensive block a week – not the other way around. Rule #4: Learn the Three Skills That Make You Useful You do not need deep knowledge in the field, such as a PhD in biostatistics. Rather, you need to have a sufficient level of statistical literacy to be able to participate in research: Reference management software knowledge (Zotero, EndNote) Basic statistical concepts (descriptive statistics, p-value, confidence interval) to be able to read and write a results section and contribute to it Literature search strategy (PubMed filters, Boolean operators, inclusion/exclusion criteria) These are the key points that I find important for someone to be on a team of researchers and not a dead weight. Your 4-Week Litmus Test Before you commit months to a project, run it through this checklist: Can I describe this project in one sentence? Is there a realistic finish line inside 3 months? Do I have (or can I quickly learn) the skill it requires? Does it leave my USMLE study schedule intact? If you checked all four — proceed. If you didn’t, it’s the wrong project, not the wrong idea. The Real Question It’s not “do I have time for research while studying for USMLE?” It’s “can I afford to submit an application with an empty research section next cycle?” One case report, one systematic review, one solid mentor — that’s a realistic 2026 profile, built without sacrificing your board scores. Start smaller than feels impressive. Finish it. Then start the next one.

How Can an IMG Build a Strong Research Profile for U.S. Residency? Imagine two IMaG applicants. Both have good Step scores and good letters. One has three vaguely related “in progress” projects on their CV, none published. The other has two finished case reports, a poster presentation, and a QI project that directly relates to their target specialty. Who do you think a program director remembers?  IMGs, if you’re staring at a blank CV and don’t even know where to start on research, you’re not alone – and the good news is, you don’t need a lab or a PhD to build something impressive. You need a game plan. Start Small, Then Climb the Ladder It’s not to be expected that your first project should be a landmark study so begin by:  A single interesting case encounter, when properly written up, provides a complete overview of the entire publication process. Literature reviews are very useful for getting familiar with the main journals and terminology in your field.  Entering data or drawing up charts—though dull—is usually the way to get started with a busy researcher who afterwards becomes your mentor.  When you’ve already done one or two of these, you can then move on to retrospective chart reviews, original data analysis, and finally first-author manuscripts. Rather than viewing it as a checklist, think of it as a staircase — each step develops the necessary skill and credibility for the one that follows.  A quick check of your own situation: are you currently working on at least one deliverable that has been completed, or is everything still listed as “in progress”? In the second case, that should be your first course of action. Finding a Mentor Without Feeling Awkward About It Many IMGs get stuck at this stage, but reaching out for mentorship is usually more welcome than you might think.  * During your USCE or rotations back home, ask your supervising physician if they’re working on any projects where you could help. * Use LinkedIn and PubMed to identify researchers in your target specialty, then send a short, personalized message about one of their recent studies.  * Attend conferences whenever you can, and don’t be afraid to introduce yourself or join conversations, especially after Q&A sessions. Make It Relevant, Not Just Impressive Program directors aren’t really looking at how many projects you started. They want to see what you actually finished. One solid, PubMed-indexed paper is usually more valuable than five projects that never made it past the draft stage. Where to Get Structured Help Having a lot of publications is great, but if they’re all over the place, they may not tell a clear story about your interests. A few projects that connect with the specialty you’re applying to can make a much stronger impression. For example, if you’re interested in pathology, case reports that include meaningful histopathology findings can help show that interest. If family medicine is your goal, research focused on health disparities, preventive care, or access to primary care may be more relevant. The same idea applies to your personal statement and CV. Don’t just list your publications or research experiences. Talk about why you chose those projects, what you learned from them, and how they shaped the way you think about patient care. Numbers can show what you’ve done, but the story behind your work is what people are more likely to remember.  Trial and error works, but it’s slow — and for IMGs juggling USCE, exams, and visas, time is the one resource you can’t get back. That’s why many applicants look for structured mentorship instead of figuring it out alone. If that’s the route you want, **Dr. Indranil Basu Ray’s research course** is worth looking into — it’s built specifically to walk IMGs through the research process step by step, pairing them with hands-on project experience and mentorship aimed at real, publishable outcomes rather than vague promises. Your Move Before you close this tab, take a second to ask yourself: what’s one small research task you could actually start this week? Maybe it’s drafting a case report, sending a cold email to a potential mentor, or even just figuring out what your next step should be. Building your research profile takes time. You don’t need to have everything figured out or wait until you feel completely ready. Just start with something small and keep going.  Your CV isn’t going to build itself, but it also doesn’t have to feel overwhelming. Sometimes, all you need is one clear first step.

How to Get Research Experience as an International Medical Graduate (IMG) Research experience has become one of the most valuable — and most misunderstood — parts of an International Medical Graduate’s residency application. Program directors want to see evidence of scholarly activity, but most IMGs assume this means flying to the U.S. and working in a lab for a year. In reality, there are several accessible paths, many of which can be started from home country before ever setting foot in the United States. Choose the Right Type of Research Not all research is created equal, and picking the right category early saves months of wasted effort. Remote and database research is the most practical starting point for IMGs still abroad. Systematic reviews, meta-analyses, and large database studies using public datasets like the National Inpatient Sample (NIS) or NHANES require no visa, no lab access, and no relocation. All you need is a laptop, astatistics foundation, and a mentor willing to guide the project. Clinical research — retrospective chart reviews and patient data analysis — is widely considered the most IMG-friendly route for residency purposes. It’s faster to complete than basic science work and demonstrates the kind of clinical reasoning program directors want to see.  Basic science research involves wet lab work and typically takes longer to reach publication. It’s a stronger fit for applicants targeting academic or research-heavy programs, but it’s a slower, more resource-intensive path. Find Opportunities Remotely or Locally You don’t need to be in the U.S. to start building a research portfolio. Start in your home country. Many IMGs overlook the fact that local academic physicians, or North American-trained faculty working internationally, can be excellent research partners. Designing a local study or drafting a systematic review and submitting it to an international journal builds real, citable experience. Build your skills online. Free and low-cost resources — YouTube channels, Coursera courses, and specialty-specific study groups — can teach the basics of biostatistics and scientific writing before you approach anyone for a position. Join guided programs. Structured mentorship platforms, such as IMG Helping Hands, are designed specifically to walk applicants through the research and publication process from scratch, which is useful if you don’t yet have a network of your own. Contact U.S. Mentors Through Cold Emailing Cold emailing remains one of the highest-yield strategies for IMGs, but it works far better when done strategically rather than as a mass mailing exercise. Target the right people. Department chairs are usually overwhelmed with requests and rarely reply. Assistant and associate professors who are actively publishing in your specialty of interest are more likely to have both the time and the motivation to bring on help. Find funded labs first. Tools like NIH RePORTER let you search for physicians holding active grants — a strong signal that they may have funding available for a research assistant, even a remote one. Keep the email short and specific. Reference a paper the physician actually wrote, state clearly what skills or availability you bring, and ask directly whether they need remote or onsite assistance. Vague, generic emails asking to “learn under” someone tend to be ignored; specific, low-friction offers to help get replies.  Putting It Together The common thread across all of these approaches is that IMGs don’t need to wait for a U.S. visa or a plane ticket to start building a research CV. A well-executed systematic review from abroad, a retrospective chart review coordinated remotely, or a single well-targeted cold email to a funded lab can each open the door to the kind of scholarly activity residency programs look for. The applicants who succeed tend to be the ones who start early, pick a research type that matches their circumstances, and treat outreach as a specific, targeted skill rather than a numbers game.  If you’re ready to move from strategy to execution, the next steps are identifying your target specialty, deciding whether you’re pursuing this remotely or in the U.S., and drafting outreach emails tailored to the faculty you’ve identified through tools like NIH RePORTER.

Dual Antiplatelet Therapy: One-Size Doesn’t Fit All After PCI Written By: Dr. Janhvi Ajmera When someone gets a percutaneous coronary intervention (PCI), which involves the use of stents to open blocked arteries, doctors usually prescribe dual antiplatelet therapy (DAPT). This means taking two medications to prevent blood clots- aspirin and a P2Y₁₂ inhibitor (such as clopidogrel, ticagrelor, or prasugrel). The idea is to reduce the risk of heart attacks and stent clots. Sounds smart, but here’s the twist: recent trials suggest that how much benefit vs. risk you get from that combo highly depends on your individual risk profile. What New Studies Reveal Two big, recent trials presented at ESC 2025 are shedding light: TARGET-FIRST examined low-risk patients who had undergone “complete revascularization” (i.e., no residual clogged arteries after PCI). In them, stopping aspirin after just 1 month and continuing only the P2Y₁₂ inhibitor did not significantly increase ischemic events. But bleeding dropped by roughly half. But then there’s NEO-MINDSET, with a more typical group (older, more comorbidities, etc.). In that trial, stopping aspirin almost immediately didn’t meet the noninferiority margin. Sure, bleeding was less, but there was a modest increase in ischemic events (stroke, MI, etc.) beyond acceptable limits. Why It Matters for You These studies tell us: Personal risk stratification matters more than blanket rules. Not everyone benefits from long DAPT; for some, shorter or modified therapy may reduce bleeding without raising clot risks too much. Low-risk patients – those with complete revascularization, fewer comorbidities, and a stable situation, might do well with early de-escalation (i.e., stop aspirin early). High-risk patient – with MI, hypertension, diabetes, prior MI, etc, probably still need the usual longer DAPT combo, because their risk of ischemia may outweigh bleeding risk. Bleeding vs. Ischemic Trade-Off – It’s like walking a tightrope. Every medicine that reduces clot risk increases bleeding risk; so the sweet spot depends on how “bleed-prone” you are (age, kidney function, other meds, etc.). Practical Takeaway: What to Discuss With Your Cardiologist If you or someone you care about is on or considering DAPT after PCI: Ask what risk category you fall into: low vs high ischemic risk / bleeding risk. Check if “complete revascularization” was really achieved. Are there still blockages that weren’t treated? Find out which P2Y₁₂ inhibitor is being used (clopidogrel vs ticagrelor vs prasugrel), some are more potent (and riskier) than others. Ask whether a plan exists for reassessment: e.g., can you drop aspirin after 1 month, or do you need full DAPT for longer? Monitor follow-up closely: any signs of bleeding? Any symptoms of ischemia (new pain, unusual fatigue)? The Bottom Line DAPT is a powerful medicine. But “powerful” means it can help or hurt, depending on the patient. The latest evidence suggests moving away from “always DAPT for X months” toward personalized antiplatelet therapy: shorter durations, tailored drug choices, careful risk balancing. If you’re dealing with PCI recovery, use what these studies teach to have a smart, evidence-based conversation with your doctor, because your ideal DAPT duration might be very different from someone else’s. REFERENCES: Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short? | Journal of the American Heart Association https://share.google/bLrbOsBmo5YlFlGhj  New trial evidence on the use of blood thinners after coronary stenting https://share.google/O7vp8BxzJMmJ86q08  Source: European Society of Cardiology https://share.google/v2znHU7DArK5bOA1X Pregabalin & Heart Failure Colchicine & Cardiovascular Protection